Skip to content
Friday, 6 November 2026
Inspire.News

Unveiling truth, one story at a time

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
Image: South China Morning Post

For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications, while traditional craniotomy resection…

Full story

Continue reading this story on South China Morning Post, the publisher that reported it.

Read the full story at South China Morning Post ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business · Asian

See all